Patents by Inventor Per Mårin

Per Mårin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6846800
    Abstract: Methods for treating a patient for insulin resistance to decrease the insulin resistance in a patient having Metabolic Syndrome comprising Primary Insulin Resistance and abdominal/visceral obesity comprise administering to the patient growth hormone or a functional derivative thereof in an amount effective for decreasing insulin resistance of the patient.
    Type: Grant
    Filed: March 31, 1998
    Date of Patent: January 25, 2005
    Assignee: Pharmacia AB
    Inventors: Gudmundur Johannsson, Per Mårin, Lars Lönn, Malin Ottosson, Kaj Stenlöf, Per Björntorp, Lars Sjöström, Bengt-Åke Bengtsson
  • Patent number: 6274582
    Abstract: Human growth hormone is used in combination with a cortisol synthesis inhibitor, in particular ketoconazole, for prevention or treatment of conditions related to Metabolis Syndrome (Neuroendocrine Syndrome). Administration can be supplemented by a sex hormone selected from testosterone and natural or synthetic estrogen. Also disclosed are corresponding pharmaceutical compositions.
    Type: Grant
    Filed: August 24, 1999
    Date of Patent: August 14, 2001
    Assignee: Cortendo AB
    Inventor: Per Mårin